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Microbiology and infectious disease are 
replete with examples of ‘the iceberg 
phenomenon’ which, simply put, des- 
cribes the fact that for every person 
suffering disease from a given micro- 
organism, a number of others are infec- 
ted but do not suffer the characteristic 
illness ascribed to that pathogen. This 
variable expression of pathogenic prop- 
erties is true of all but a few microorg- 
anisms of man, and the newly identified 
virus HIV, associated with AIDS, will 
in fact be exceptional if it uniformly 
initiates the destructive processes which 
set the stage for immunosuppression 
and AIDS. 
It is well appreciated that a number 
of ‘risk factors’ help predict with a high 
degree of accuracy which persons are 
likely to become infected with HIV,l a 
virus which is fortunately so fastidious 
and fragile that its spread among 
humans depends almost exclusively on 
sexual, blood or perinatal transmission. 
Within groups of infected individuals 
(that is, persons who have antibody to 
HIV), it is still uncertain who will 
develop AIDS or related diseases, but 
prospective studies are being pursued 
vigorously in hopes of identifying 
specific environmental or behavioral 
components of life style that might 
prove predictive of good or bad out- 
comes of established HIV infections. 
The range of possibilities is wide: there 
have been individuals infected since 
earliest recognition (1978) of the U.S. 
epidemic who remain healthy, albeit 
infected and infectious eight years later. 
Conversely, some AIDS patients have 
sickened and died in less than a year; 
and in the highest known seropositive 
risk groups, the rate of AIDS occurring 
after three years’ infection is less than 
50% .z Gloom pervades the estimates of 
the future of these seropositive ‘worried 
well’ but they may not hold the full key 
to the intrinsic pathogenicity of AIDS, 
for they are far from the norm in many 
ways which may have bearing: that is to 
say, a number of potential ‘co-factors’ 
are intrinsic to their membership in risk 
groups to start with. 
Perhaps the simplest example would 
be that of the severe hemophiliacs who 
were dependent on factor VIII concen- 
trate obtained from plasmapheresis 
donors for their hemostasis and thus 
were squarely in the path of the new 
virus when it entered the U.S. blood 
supply prior to 1983. Factor VIII 
concentrate is prepared from the pooled 
plasma of literally thousands of donors, 
and the virus was evidently able to 
survive the prevailing fractionation 
procedures, so that over 90% of the 
cohort of severe hemophiliacs became 
seropositive prior to the institution of 
effective control measures (donor self- 
exclusion, heat-treatment of concen- 
trate and donor antibody screening). 
These hemophiliacs were important 
‘sentinels’ of the blood supply, and 
intensive studies were launched prior to 
recognition of the new virus, looking 
for explanations of their involvement in 
the burgeoning epidemic. In this context 
it was recognized that they were being 
bombarded with foreign antigens by 
virtue of their factor VIII treatment and 
were, in fact, measurably immunosup- 
pressed prior to virus infe~t ion .~  This 
helped to give rise to the theory of 
antigenic overload as a possible mecha- 
nism of AIDS, and while the discovery 
of the new virus ablated that theory as 
a selfcontained explanation of AIDS, 
antigenic overload remains as a possible 
co-factor which might augment or ac- 
celerate the pathogenesis of immune 
deficiency. 
Hemophiliacs present the mildest and 
simplect examples of this kind of 
postulated co-factor: other than the 
alloantigens represented in factor VIII 
their microbial and social environment 
is relatively commonplace, and it is of 
interest to note that they are at once the 
highest risk group for HIV infection 
and the lowest (among the risk groups) 
for AIDS.2 
In terms of antigenic stimulation and 
overload, the other risk groups present 
much more dramatic examples. Gay 
men with multiple sexual partners have 
multiple infectious diseases, for para- 
sites, bacteria and a variety of viruses 
thrive in the context of sexually active 
gay life styles. Similarly, i.v. drug users 
bombard themselves not only with HIV 
(in the act of needle-sharing) but also 
are notorious for their plethora of 
infections such as the viral hepatitides 
and bacterial endocarditis. Haitians, 
whose role early in the epidemic was 
inexplicable but significant, share their 
terrain with a wide variety of parasites, 
suffer from endemic tubercular infec- 
tions, and again conform to the pattern 
of potential antigenic overstimulation. 
The mechanism whereby these co- 
factors might play an additive or 
synergistic role with HIV is not hard to 
postulate: the proliferation of T4 helper 
cells at the initiation of the immune 
response would at the very least put a 
‘stretch’ on a weakened immunologic 
capability; but it also might activate 
HIV simultaneously with amplification 
of the susceptible T4 helper cell sub- 
strate, for which the virus clearly has 
both a taste and a lytic potential3 Thus 
a vicious circle of viral replication and 
enlargement of the pool of suscept- 
ible cells is easily imagined, perhaps 
reaching a point of no return with 
irretrievable lysis-mediated depletion of 
T4 helper cells - the immunologic set- 
ting for the opportunistic infections 
diagnostic of AIDS. 
Another co-factorial mechanism 
which might be operative in the pro- 
gression from asymptomatic infection 
to overt disease is coincident immune 
suppression caused by factors other 
than HIV: a number of viruses preva- 
lent among gay men have transient 
immunosuppressive effects of their 
own - notably cytomegal~virus~ and 
Epstein-Barr viruss - and an unhappy 
coincidence of timing might result in 
irreversible damage to the immune 
system. Similarly, semen has immuno- 
suppressive effects,’ as do a number of 
drugs of abuse (marijuana as well as the 
opiates and nitrites). 
Another kind of immunosuppression 
corresponds in an interesting way to an 
already-established co-factor of sub- 
stantial risk: i.e. pregnancy. It is worth 
reviewing briefly the information con- 
cerning the adverse effect of pregnancy 
.on asymptomatic HIV infection, for 
while the numbers are small they are 
dramatic. In a study in Miami, Scott 
and colleagues initially identified several 
infected women by the occurrence of 
AIDS in their infants.* Of these asymp- 
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tomatic women, 13 subsequently 
became pregnant and delivered 15 
second children who could be followed. 
By one year of age only 4 infants were 
uninfected, one was asymptomatically 
infected, five had immunologic abnorm- 
alities and 5 had AIDS with an average 
age of onset of 4 months. The extent of 
the adverse effect on these offspring was 
unexpected, in that it is nearly unique 
among congenital viral infections to 
feature successive, pathologically signi- 
ficant intra-uterine infections. However, 
the most striking finding of the study 
was that more than half the mothers 
sickened and four had died of AIDS 
within a very few months of the second 
delivery - a pace and rate of exacerba- 
tion greater than had been recognized 
in any other high-risk cohort. 
This effect of pregnancy on the 
virus-host relationship is worthy of 
study. It is a fascinating aspect of 
immunology that gestational immuno- 
suppression occurs to some extent; in 
the second and third timesters one can 
measure depressed lymphocyte numbers 
and functions which generally return to 
normal by one month po~t-partum.~ 
That this should occur is intuitively 
reasonable since the maternal environ- 
ment must remain tolerant to alien 
antigens for many months. There may 
be clues to the specific synergism 
between pregnancy and HIV which are 
useful in providing broader insight 
about the pathogenesis of AIDS; but 
for the present it constitutes a strongly 
documented warning that pregnancy 
may be very davgerous to the health of 
an infected woman. 
As a final possible example of 
additive immune suppression it is evi- 
dent that superinfection with more than 
one variant of HIV can occur.1o The 
potential of this mechanism for satura- 
ting (and destroying) susceptible cells 
has not been assessed, but the continued 
intercourse among multiple HIV-posi- 
tive sexual partners may carry incre- 
mental risks. Note that to the extent 
that this superficial infection phenome- 
non does occur, the hoped-for vaccine 
strategy of utilizing interfering retro- 
viruses such as HIV-11" may be less 
promising than would at first appear. 
Up to this point, the discussion has 
focused on individuals who were inher- 
ently 'normal' at least at the time of 
acquisition of HIV. It is noteworthy, 
however, that several risk groups are 
composed of people who were not 
immunologically normal at time of first 
exposure. It has been suggested, for 
instance, that the different distribution 
of AIDS between the sexes in central 
Africa (relative to this distribution in 
other countries) may reflect a different 
human substrate for the virus.I2 The 
most common factor cited in this argu- 
ment is the underlying immunosup- 
pression attendant on malarial preva- 
lence in those regions in which AIDS is 
now epidemic. This line of reasoning is 
almost exactly parallel to that proposed 
to explain the relationship between 
Burkitt's lymphoma and Epstein-Barr 
virus, and it is certainly an interesting 
avenue to explore, since the equal 
male-female distribution in African 
patients is a source of nervous worry 
lest it represent a premonitory change in 
the nature of HIV itself. There are 
actually a number of alternative expla- 
nations for the divergent African ex- 
perience with HIV, however, including 
patterns of needle use in clinics where 
sexually transmitted diseases are 
treated,13 and practices of clitorectomy 
which might either provide relatively 
easy access to the bloodstream during 
vaginal intercourse or alter patterns of 
heterosexual practice. Unfortunately 
these matters are caught up in a rather 
heated cross-cultural debate, and it may 
take a while for tempers to cool and 
sensitivities to ease enough to permit 
progress in understanding the divergent 
epidemiology of AIDS in Africa.14 
Infants are another immunologically 
abnormal group, and the more prema- 
ture they are, the greater their immun- 
ological abnormality. The significant 
shortening of average incubation in- 
terval in AIDS infants from 2 or more 
years to less than a year has been 
explained on that basis, at least in a 
general way. Furthermore, those infants 
who acquired their viral infection 
through multiple blood transfusions 
could also be viewed as candidates for 
antigenic overload, in view of the abun- 
dance of foreign histocompatibility 
antigens represented in the repeated 
transfusions. 
Another kind of immunologic ab- 
normality worthy of considerable con- 
cern is that ascribed to the process of 
aging. It has been shown that there 
is-or at least can be-a  significant 
attrition of immunologic response capa- 
bilities in the seventh and later decades. 
This is probably not trivial, as illustra- 
ted by the well-known fact that the risk 
of herpes zoster (or so-called shingles) 
goes up precipitously with advancing 
age. While this age group is not 
represented at present in the population 
of asymptomatic, infected persons, it 
may loom large as a co-factor when that 
cohort ages. 
To this point the discussion has 
centred on HIV and/or direct observa- 
tions from experience with the AIDS 
epidemic which suggest avenues of 
explanation for variable clinical out- 
come. However, it is interesting and 
perhaps useful to look at other diseases 
in which clinical expression seems to be 
the summation of disparate stimuli. 
Perhaps the most pertinent would be 
the area of latency and reactivation of 
herpes simplex. The link between emo- 
tional states and exacerbation of cold 
sores, for instance, is well accepted, and 
yet intense study directed to the estab- 
lishment and maintenance of herpes 
simplex latency has as yet yielded no 
compelling insight to explain such 
connections to emotional and neuro- 
behavioral events. Insights in this area 
could well have substantial bearing on 
the pathogenesis of AIDS. 
In a similar vein, there is an even less 
satisfactory but persistent association 
between acute emotional perturbation 
and the abrupt onset of malignancy, 
which might be a related phenomenon, 
if it is true that the immune system is 
constantly exercising a surveillance 
function to minitor for abnormal cells. 
If the immunologic component of grief 
reactions, for instance, is a contributor 
to the progression of symptomatic 
disease in the context of AIDS, it will be 
critically important to learn that and to 
deal with it in counselling of infected 
persons. 
In summary, then, there is no shor- 
tage of co-factors to be considered as 
possible contributors to disease onset 
and progression in the AIDS epidemic. 
The urgency of their assessment is 
manifest in the fact that an estimated 
1-2 million asymptomatic individuals 
in the United States alone now live 
under the potential threat of a lethal 
disease,15 and the likelihood of that 
occurring may be not only influenced 
but actually determined by specific 
co-factors. Some of them-such as 
pregnancy, immunosuppressive drugs, 
and exposure to multiple infectious 
agents - may be fairly easy to control if 
we understand their significance well 
enought to justify the effort. Many of 
them submit to health education strate- 
gies in a manner quite analogous to 
counselling concerning juvenile-onset 
diabetes. In fact, the diabetes analogy 
is quite useful in thinking about this 
problem. In that instance the new 
juvenile diabetic must learn to live with 
the realization that his islet cells are not 
to be relied upon and that life-style 
changes will be necessary; but once 
those accommodations are made, he 
can anticipate relatively good health 
and longevity. In the instance of HIV 
infection, there is room for hope that 
the same concept applies to T4 helper 
cells: they, too, are weakened and 
fragile, but with enough insight about 
determinants of progression in the 
context of virus infection, it may be 
possible through health education to 
define life styles which facilitate con- 
tinued well-being for many years despite 
the lurking threat of viral reactiva- 
tion. As the shadow of HIV infection 
grows longer and as the likelihood of 
treatment strategies remains ephemeral, 
these avenues of investigation may 
promise solid hope for the health of a 
very large number of infected persons 
and are worthy of intensive pursuit. 
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